Clinical Trial Update: Safety and Pharmacokinetics of Sustained-release Depot Tacrolimus: A First-in-human Study [EARLY_Phase 1]

View source ↗

Summary

First-in-human Phase 1 safety and pharmacokinetic study of a sustained-release depot tacrolimus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Organ Transplant Rejection
• Psoriasis

Drugs mentioned

• Tacrolimus sustained-release depot (tacrolimus)

Snippet

Sponsor: Auritec Pharmaceuticals | Conditions: Organ Transplant Rejection, Psoriasis | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2019-06-11